BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 32.00
+1.00 (3.23%)
Sep 30, 2026, 1:30 PM CST
BRIM Biotechnology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 10.6 | 5.49 | 0.33 | 0.09 | 0.53 | 0.36 |
Revenue Growth | 427.82% | 1548.65% | 270.00% | -82.89% | 46.11% | -99.60% |
Gross Profit Gross Profit Growth | -1.41 | 1.25 | 0.02 | 0.09 | 0.53 | 0.36 |
Operating Income Operating Income Growth | -459.94 | -452.97 | -344.79 | -694.13 | -218.33 | -93.22 |
Net Income Net Income Growth | -428 | -436.45 | -315.47 | -688.02 | -274.28 | -105.45 |
Earnings Per Share EPS Growth | -3.26 | -3.32 | -2.70 | -6.84 | -3.85 | -1.78 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pepsico and Its Subsidiaries Pepsico and Its Subsidiaries Growth | - | 1.37 | - | - | - | - |
Quanfu Quanfu Growth | 4.78 | 4.12 | 0.33 | 0.09 | 0.53 | 0.36 |
Total Total Growth | 10.6 | 5.49 | 0.33 | 0.09 | 0.53 | 0.36 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 981.5 | 1,158 | 1,849 | 1,696 | 837.99 | 423.59 |
Total Debt Total Debt Growth | 10.28 | 15.96 | 7.78 | 3.59 | 6.44 | 3.16 |
Net Cash (Debt) Net Cash Growth | 971.22 | 1,142 | 1,841 | 1,692 | 831.55 | 420.42 |
Net Cash Growth | -41.31% | -37.94% | 8.80% | 103.48% | 97.79% | 157.57% |
Net Cash Per Share Net Cash Per Share Growth | 7.40 | 8.69 | 15.78 | 16.83 | 11.66 | 7.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -334.44 | -329.17 | -279.24 | -596.89 | -171.87 | -112.57 |
Capital Expenditures CapEx Growth | -2.28 | -0.8 | -2.9 | -2.26 | -1.11 | -0.78 |
Free Cash Flow Free Cash Flow Growth | -336.72 | -329.97 | -282.14 | -599.15 | -172.98 | -113.35 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | -13.32% | 22.77% | 6.61% | 100.00% | 100.00% | 100.00% |
Operating Margin | -4337.40% | -8250.89% | -103539.04% | -771250.00% | -41506.84% | -25893.06% |
Pretax Margin | -4372.19% | -8213.30% | -94735.74% | -764468.89% | -52143.92% | -29291.39% |
Profit Margin | -4036.18% | -7949.94% | -94735.74% | -764468.89% | -52143.92% | -29291.39% |
FCF Margin | -3175.39% | -6010.38% | -84726.73% | -665723.33% | -32885.74% | -31485.83% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 388.99 | 721.88 | 12216.14 | 38520.36 | 6763.57 | - |